跳转至内容
Merck
CN

4370285

Trypsin, TPCK-Treated

别名:

Trypsin, TPCK treated for Cell Culture

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

UNSPSC Code:
12352204
EC Number:
232-650-8
NACRES:
NA.56
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


shipped in

dry ice

storage temp.

−20°C

General description

胰蛋白酶是一种丝氨酸蛋白酶,可特异性水解赖氨酸及精氨酸残基的羧基侧的多肽键。该款修饰后的胰蛋白酶经过甲苯磺酰基-L-氨基联苯氯甲基酮 (TPCK) 处理,可使外源性糜蛋白酶失活。每个包装含8个小瓶,每瓶含25 μg。

Application

TPCK处理的胰蛋白酶已被用于:
  • 作为杜尔贝科改良伊格尔培养基(DMEM)的补充剂,用于上皮样猪肾细胞系(LLC-PK1) 的猪Delta冠状病毒(PDCoV)感染实验
  • 分离人脐静脉内皮细胞(HUVEC) 用于膜联蛋白-V/碘化丙啶 (PI) 染色测定
  • 用于多循环复制动力学的最小必需培养基 (MEM)

Biochem/physiol Actions

N--对甲苯磺酰基-L-苯丙氨酸氯甲基酮(TPCK) 可用作糜蛋白酶的不可逆抑制剂。胰蛋白酶诱导人纤维细胞分化。胰蛋白酶被广泛用于蛋白质组学中的蛋白质样品消化。在细胞培养中,进行胰蛋白酶消化是为了使贴壁细胞彼此分开并离开培养容器壁。


Still not finding the right product?

Explore all of our products under Trypsin, TPCK-Treated


pictograms

Health hazardExclamation mark

signalword

Danger

Hazard Classifications

Eye Irrit. 2 - Resp. Sens. 1 - Skin Irrit. 2 - STOT SE 3

target_organs

Respiratory system

存储类别

10 - Combustible liquids

flash_point_f

Not applicable

flash_point_c

Not applicable

法规信息

低风险生物材料
动植物源性产品

此项目有



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助,请联系 客户支持

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库



Michael J V White et al.
PloS one, 8(8), e70795-e70795 (2013-08-21)
Trypsin-containing topical treatments can be used to speed wound healing, although the mechanism of action is unknown. To help form granulation tissue and heal wounds, monocytes leave the circulation, enter the wound tissue, and differentiate into fibroblast-like cells called fibrocytes.
Zdeněk Perutka et al.
Molecules (Basel, Switzerland), 23(10) (2018-10-17)
Trypsin is the protease of choice for protein sample digestion in proteomics. The most typical active forms are the single-chain β-trypsin and the two-chain α-trypsin, which is produced by a limited autolysis of β-trypsin. An additional intra-chain split leads to
Zhonghui Ling et al.
Reproductive biology, 21(2), 100483-100483 (2021-02-26)
Vascular endothelial cell damage is regarded as the carrier in the progression of the pathological changes of preeclampsia (PE) from the placenta to maternal organs. MicroRNA (miR)-141-3p was aberrantly expressed during PE pathogenesis. We investigated the role of miR-141-3p in



全球贸易项目编号

货号GTIN
4370285-1KT04061826723784